HEADER MEMBRANE PROTEIN 05-APR-22 7ZH6 TITLE STRUCTURE OF HUMAN OCT3 IN COMPLEX WITH INHIBITOR CORTICOSTERONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SOLUTE CARRIER FAMILY 22 MEMBER 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EXTRANEURONAL MONOAMINE TRANSPORTER,EMT,ORGANIC CATION COMPND 5 TRANSPORTER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC22A3, EMTH, OCT3; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS ORGANIC CATION TRANSPORTER, MAJOR-FACILITATOR SUPERFAMILY, SLC22 KEYWDS 2 FAMILY, CORTICOSTERONE-SENSITIVE, MEMBRANE TRANSPORT, STEROID KEYWDS 3 HORMONES, DRUG TRANSPORTER, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR B.KHANPPNAVAR,V.KORKHOV REVDAT 2 19-APR-23 7ZH6 1 JRNL REVDAT 1 09-NOV-22 7ZH6 0 JRNL AUTH B.KHANPPNAVAR,J.MAIER,F.HERBORG,R.GRADISCH,E.LAZZARIN, JRNL AUTH 2 D.LUETHI,J.W.YANG,C.QI,M.HOLY,K.JANTSCH,O.KUDLACEK, JRNL AUTH 3 K.SCHICKER,T.WERGE,U.GETHER,T.STOCKNER,V.M.KORKHOV,H.H.SITTE JRNL TITL STRUCTURAL BASIS OF ORGANIC CATION TRANSPORTER-3 INHIBITION. JRNL REF NAT COMMUN V. 13 6714 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 36344565 JRNL DOI 10.1038/S41467-022-34284-8 REMARK 2 REMARK 2 RESOLUTION. 3.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 7ZH0 REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : AB INITIO MODEL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : 95.000 REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.670 REMARK 3 NUMBER OF PARTICLES : 139149 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7ZH6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-APR-22. REMARK 100 THE DEPOSITION ID IS D_1292122247. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN OCT3 IN COMPLEX WITH REMARK 245 INHIBITOR CORTICOSTERONE REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6100.00 REMARK 245 ILLUMINATION MODE : SPOT SCAN REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 ARG A 79 REMARK 465 GLY A 80 REMARK 465 PRO A 81 REMARK 465 GLU A 82 REMARK 465 PRO A 83 REMARK 465 PRO A 84 REMARK 465 GLU A 85 REMARK 465 ARG A 86 REMARK 465 GLU A 96 REMARK 465 ALA A 97 REMARK 465 ALA A 98 REMARK 465 ASN A 99 REMARK 465 ASP A 100 REMARK 465 SER A 101 REMARK 465 ALA A 102 REMARK 465 SER A 103 REMARK 465 ALA A 104 REMARK 465 THR A 105 REMARK 465 SER A 106 REMARK 465 ALA A 107 REMARK 465 LEU A 108 REMARK 465 SER A 109 REMARK 465 CYS A 110 REMARK 465 ALA A 111 REMARK 465 ASP A 112 REMARK 465 PRO A 113 REMARK 465 LEU A 114 REMARK 465 ALA A 115 REMARK 465 ALA A 116 REMARK 465 PHE A 117 REMARK 465 PRO A 118 REMARK 465 ASN A 119 REMARK 465 ARG A 120 REMARK 465 GLY A 316 REMARK 465 LYS A 317 REMARK 465 TYR A 318 REMARK 465 LEU A 319 REMARK 465 SER A 320 REMARK 465 SER A 321 REMARK 465 ASN A 322 REMARK 465 TYR A 323 REMARK 465 SER A 324 REMARK 465 GLU A 325 REMARK 465 ILE A 326 REMARK 465 THR A 327 REMARK 465 VAL A 328 REMARK 465 THR A 329 REMARK 465 ASP A 330 REMARK 465 GLU A 331 REMARK 465 GLU A 332 REMARK 465 ILE A 374 REMARK 465 ILE A 375 REMARK 465 GLY A 376 REMARK 465 GLY A 377 REMARK 465 LEU A 535 REMARK 465 GLY A 536 REMARK 465 SER A 537 REMARK 465 PRO A 538 REMARK 465 HIS A 539 REMARK 465 SER A 540 REMARK 465 CYS A 541 REMARK 465 LYS A 542 REMARK 465 CYS A 543 REMARK 465 GLY A 544 REMARK 465 ARG A 545 REMARK 465 ASN A 546 REMARK 465 LYS A 547 REMARK 465 LYS A 548 REMARK 465 THR A 549 REMARK 465 PRO A 550 REMARK 465 VAL A 551 REMARK 465 SER A 552 REMARK 465 ARG A 553 REMARK 465 SER A 554 REMARK 465 HIS A 555 REMARK 465 LEU A 556 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CD1 ILE A 523 OE2 GLU A 533 1.61 REMARK 500 OG1 THR A 28 OH TYR A 185 2.14 REMARK 500 CE2 PHE A 4 NE ARG A 293 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 4 -7.34 -56.03 REMARK 500 SER A 66 74.00 53.69 REMARK 500 ALA A 77 -59.45 73.23 REMARK 500 ARG A 89 41.62 36.15 REMARK 500 CYS A 90 68.37 31.68 REMARK 500 LEU A 124 73.02 -113.03 REMARK 500 ARG A 128 -31.62 -142.98 REMARK 500 SER A 236 51.35 -91.39 REMARK 500 LYS A 237 -36.43 -133.77 REMARK 500 VAL A 288 70.99 57.93 REMARK 500 ARG A 298 -3.92 83.90 REMARK 500 LYS A 300 -56.13 -143.64 REMARK 500 TYR A 380 -48.32 -132.28 REMARK 500 GLU A 402 -6.45 75.59 REMARK 500 GLU A 497 -3.86 69.25 REMARK 500 GLU A 519 -12.66 75.84 REMARK 500 THR A 520 57.13 36.19 REMARK 500 ALA A 524 -134.18 59.96 REMARK 500 THR A 528 -119.81 37.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-14725 RELATED DB: EMDB REMARK 900 STRUCTURE OF HUMAN OCT3 IN COMPLEX WITH INHIBITOR CORTICOSTERONE DBREF 7ZH6 A 1 556 UNP O75751 S22A3_HUMAN 1 556 SEQRES 1 A 556 MET PRO SER PHE ASP GLU ALA LEU GLN ARG VAL GLY GLU SEQRES 2 A 556 PHE GLY ARG PHE GLN ARG ARG VAL PHE LEU LEU LEU CYS SEQRES 3 A 556 LEU THR GLY VAL THR PHE ALA PHE LEU PHE VAL GLY VAL SEQRES 4 A 556 VAL PHE LEU GLY THR GLN PRO ASP HIS TYR TRP CYS ARG SEQRES 5 A 556 GLY PRO SER ALA ALA ALA LEU ALA GLU ARG CYS GLY TRP SEQRES 6 A 556 SER PRO GLU GLU GLU TRP ASN ARG THR ALA PRO ALA SER SEQRES 7 A 556 ARG GLY PRO GLU PRO PRO GLU ARG ARG GLY ARG CYS GLN SEQRES 8 A 556 ARG TYR LEU LEU GLU ALA ALA ASN ASP SER ALA SER ALA SEQRES 9 A 556 THR SER ALA LEU SER CYS ALA ASP PRO LEU ALA ALA PHE SEQRES 10 A 556 PRO ASN ARG SER ALA PRO LEU VAL PRO CYS ARG GLY GLY SEQRES 11 A 556 TRP ARG TYR ALA GLN ALA HIS SER THR ILE VAL SER GLU SEQRES 12 A 556 PHE ASP LEU VAL CYS VAL ASN ALA TRP MET LEU ASP LEU SEQRES 13 A 556 THR GLN ALA ILE LEU ASN LEU GLY PHE LEU THR GLY ALA SEQRES 14 A 556 PHE THR LEU GLY TYR ALA ALA ASP ARG TYR GLY ARG ILE SEQRES 15 A 556 VAL ILE TYR LEU LEU SER CYS LEU GLY VAL GLY VAL THR SEQRES 16 A 556 GLY VAL VAL VAL ALA PHE ALA PRO ASN PHE PRO VAL PHE SEQRES 17 A 556 VAL ILE PHE ARG PHE LEU GLN GLY VAL PHE GLY LYS GLY SEQRES 18 A 556 THR TRP MET THR CYS TYR VAL ILE VAL THR GLU ILE VAL SEQRES 19 A 556 GLY SER LYS GLN ARG ARG ILE VAL GLY ILE VAL ILE GLN SEQRES 20 A 556 MET PHE PHE THR LEU GLY ILE ILE ILE LEU PRO GLY ILE SEQRES 21 A 556 ALA TYR PHE ILE PRO ASN TRP GLN GLY ILE GLN LEU ALA SEQRES 22 A 556 ILE THR LEU PRO SER PHE LEU PHE LEU LEU TYR TYR TRP SEQRES 23 A 556 VAL VAL PRO GLU SER PRO ARG TRP LEU ILE THR ARG LYS SEQRES 24 A 556 LYS GLY ASP LYS ALA LEU GLN ILE LEU ARG ARG ILE ALA SEQRES 25 A 556 LYS CYS ASN GLY LYS TYR LEU SER SER ASN TYR SER GLU SEQRES 26 A 556 ILE THR VAL THR ASP GLU GLU VAL SER ASN PRO SER PHE SEQRES 27 A 556 LEU ASP LEU VAL ARG THR PRO GLN MET ARG LYS CYS THR SEQRES 28 A 556 LEU ILE LEU MET PHE ALA TRP PHE THR SER ALA VAL VAL SEQRES 29 A 556 TYR GLN GLY LEU VAL MET ARG LEU GLY ILE ILE GLY GLY SEQRES 30 A 556 ASN LEU TYR ILE ASP PHE PHE ILE SER GLY VAL VAL GLU SEQRES 31 A 556 LEU PRO GLY ALA LEU LEU ILE LEU LEU THR ILE GLU ARG SEQRES 32 A 556 LEU GLY ARG ARG LEU PRO PHE ALA ALA SER ASN ILE VAL SEQRES 33 A 556 ALA GLY VAL ALA CYS LEU VAL THR ALA PHE LEU PRO GLU SEQRES 34 A 556 GLY ILE ALA TRP LEU ARG THR THR VAL ALA THR LEU GLY SEQRES 35 A 556 ARG LEU GLY ILE THR MET ALA PHE GLU ILE VAL TYR LEU SEQRES 36 A 556 VAL ASN SER GLU LEU TYR PRO THR THR LEU ARG ASN PHE SEQRES 37 A 556 GLY VAL SER LEU CYS SER GLY LEU CYS ASP PHE GLY GLY SEQRES 38 A 556 ILE ILE ALA PRO PHE LEU LEU PHE ARG LEU ALA ALA VAL SEQRES 39 A 556 TRP LEU GLU LEU PRO LEU ILE ILE PHE GLY ILE LEU ALA SEQRES 40 A 556 SER ILE CYS GLY GLY LEU VAL MET LEU LEU PRO GLU THR SEQRES 41 A 556 LYS GLY ILE ALA LEU PRO GLU THR VAL ASP ASP VAL GLU SEQRES 42 A 556 LYS LEU GLY SER PRO HIS SER CYS LYS CYS GLY ARG ASN SEQRES 43 A 556 LYS LYS THR PRO VAL SER ARG SER HIS LEU HET C0R A 601 25 HETNAM C0R CORTICOSTERONE HETSYN C0R (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE FORMUL 2 C0R C21 H30 O4 HELIX 1 AA1 SER A 3 VAL A 11 1 9 HELIX 2 AA2 GLY A 15 GLY A 43 1 29 HELIX 3 AA3 GLY A 53 ARG A 62 1 10 HELIX 4 AA4 SER A 66 THR A 74 1 9 HELIX 5 AA5 THR A 139 ASP A 145 1 7 HELIX 6 AA6 VAL A 147 VAL A 149 5 3 HELIX 7 AA7 ASN A 150 TYR A 179 1 30 HELIX 8 AA8 GLY A 180 PHE A 201 1 22 HELIX 9 AA9 ASN A 204 VAL A 234 1 31 HELIX 10 AB1 GLN A 238 PHE A 263 1 26 HELIX 11 AB2 ASN A 266 TYR A 284 1 19 HELIX 12 AB3 SER A 291 ILE A 296 1 6 HELIX 13 AB4 GLY A 301 ILE A 311 1 11 HELIX 14 AB5 SER A 337 ARG A 343 1 7 HELIX 15 AB6 THR A 344 LEU A 372 1 29 HELIX 16 AB7 TYR A 380 GLU A 390 1 11 HELIX 17 AB8 GLU A 390 ILE A 401 1 12 HELIX 18 AB9 ARG A 406 PHE A 426 1 21 HELIX 19 AC1 ILE A 431 TYR A 461 1 31 HELIX 20 AC2 PRO A 462 LEU A 465 5 4 HELIX 21 AC3 ARG A 466 TRP A 495 1 30 HELIX 22 AC4 GLU A 497 MET A 515 1 19 HELIX 23 AC5 GLU A 527 VAL A 532 5 6 SHEET 1 AA1 2 TYR A 49 TRP A 50 0 SHEET 2 AA1 2 ARG A 132 TYR A 133 -1 O ARG A 132 N TRP A 50 SHEET 1 AA2 2 ARG A 92 TYR A 93 0 SHEET 2 AA2 2 LEU A 124 VAL A 125 -1 O VAL A 125 N ARG A 92 SSBOND 1 CYS A 51 CYS A 127 1555 1555 2.03 SSBOND 2 CYS A 90 CYS A 148 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000